Biogen Inc Stock Shares Outstanding

BIIB Stock  USD 216.34  4.32  2.04%   
Biogen Inc fundamentals help investors to digest information that contributes to Biogen's financial success or failures. It also enables traders to predict the movement of Biogen Stock. The fundamental analysis module provides a way to measure Biogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biogen stock.
The current year's Common Stock Shares Outstanding is expected to grow to about 283 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biogen Shares Outstanding Analysis

Biogen's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
 2021 2022 2023 2024 (projected)
Gross Profit8.9B7.9B7.3B3.9B
Total Revenue11.0B10.2B9.8B10.3B

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Biogen Shares Outstanding

    
  145.36 M  
Most of Biogen's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biogen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Biogen Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Biogen is extremely important. It helps to project a fair market value of Biogen Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Biogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biogen's interrelated accounts and indicators.
0.670.940.850.990.970.56-0.820.960.930.590.890.3-0.80.390.680.650.890.890.23-0.920.850.260.81-0.950.45-0.080.5-0.18-0.19-0.38
0.670.530.460.630.590.45-0.640.730.79-0.10.730.74-0.560.440.730.560.60.73-0.53-0.810.69-0.150.64-0.710.470.360.62-0.14-0.130.38
0.940.530.680.940.950.54-0.630.820.870.70.790.18-0.850.290.540.490.740.810.36-0.880.70.460.63-0.820.32-0.110.32-0.21-0.05-0.46
0.850.460.680.830.780.48-0.860.910.730.540.710.22-0.560.220.50.610.960.720.34-0.690.760.00.91-0.910.28-0.150.4-0.04-0.34-0.46
0.990.630.940.830.970.51-0.850.940.930.610.830.28-0.730.330.620.570.890.840.29-0.910.830.350.82-0.940.38-0.040.42-0.22-0.1-0.41
0.970.590.950.780.970.52-0.770.90.890.60.850.18-0.750.320.630.650.840.860.3-0.90.840.370.75-0.880.4-0.140.45-0.3-0.07-0.42
0.560.450.540.480.510.52-0.330.530.60.190.510.43-0.650.050.310.270.550.55-0.02-0.450.440.150.51-0.580.150.180.17-0.170.02-0.09
-0.82-0.64-0.63-0.86-0.85-0.77-0.33-0.9-0.81-0.32-0.71-0.370.37-0.33-0.62-0.58-0.91-0.71-0.090.76-0.85-0.1-0.920.9-0.4-0.08-0.490.180.150.22
0.960.730.820.910.940.90.53-0.90.910.440.890.37-0.690.440.740.730.940.870.11-0.880.90.090.9-0.980.51-0.050.6-0.14-0.28-0.28
0.930.790.870.730.930.890.6-0.810.910.350.850.53-0.760.330.620.510.860.850.01-0.920.820.30.82-0.940.350.220.41-0.350.05-0.13
0.59-0.10.70.540.610.60.19-0.320.440.350.32-0.35-0.53-0.080.090.180.460.340.84-0.440.250.360.31-0.450.01-0.45-0.080.11-0.24-0.82
0.890.730.790.710.830.850.51-0.710.890.850.320.25-0.710.50.740.810.750.880.0-0.850.860.120.7-0.840.52-0.140.61-0.27-0.21-0.2
0.30.740.180.220.280.180.43-0.370.370.53-0.350.25-0.360.290.39-0.010.360.39-0.64-0.420.3-0.170.45-0.460.170.770.3-0.010.10.58
-0.8-0.56-0.85-0.56-0.73-0.75-0.650.37-0.69-0.76-0.53-0.71-0.36-0.22-0.45-0.38-0.61-0.77-0.150.79-0.51-0.21-0.520.72-0.2-0.05-0.250.110.10.22
0.390.440.290.220.330.320.05-0.330.440.33-0.080.50.29-0.220.80.550.180.45-0.37-0.350.49-0.020.18-0.340.85-0.160.880.15-0.320.08
0.680.730.540.50.620.630.31-0.620.740.620.090.740.39-0.450.80.760.490.74-0.3-0.670.77-0.040.52-0.640.9-0.070.910.11-0.430.1
0.650.560.490.610.570.650.27-0.580.730.510.180.81-0.01-0.380.550.760.560.68-0.06-0.590.78-0.150.53-0.580.69-0.490.81-0.07-0.5-0.16
0.890.60.740.960.890.840.55-0.910.940.860.460.750.36-0.610.180.490.560.770.24-0.780.810.090.96-0.960.240.030.36-0.21-0.15-0.35
0.890.730.810.720.840.860.55-0.710.870.850.340.880.39-0.770.450.740.680.77-0.01-0.870.920.270.8-0.860.44-0.030.58-0.07-0.25-0.06
0.23-0.530.360.340.290.3-0.02-0.090.110.010.840.0-0.64-0.15-0.37-0.3-0.060.24-0.01-0.01-0.010.430.09-0.13-0.28-0.5-0.410.0-0.06-0.9
-0.92-0.81-0.88-0.69-0.91-0.9-0.450.76-0.88-0.92-0.44-0.85-0.420.79-0.35-0.67-0.59-0.78-0.87-0.01-0.8-0.2-0.760.87-0.36-0.09-0.480.170.130.11
0.850.690.70.760.830.840.44-0.850.90.820.250.860.3-0.510.490.770.780.810.92-0.01-0.80.250.86-0.850.53-0.10.66-0.14-0.26-0.09
0.26-0.150.460.00.350.370.15-0.10.090.30.360.12-0.17-0.21-0.02-0.04-0.150.090.270.43-0.20.250.1-0.14-0.10.0-0.21-0.210.34-0.29
0.810.640.630.910.820.750.51-0.920.90.820.310.70.45-0.520.180.520.530.960.80.09-0.760.860.1-0.930.230.120.39-0.12-0.19-0.13
-0.95-0.71-0.82-0.91-0.94-0.88-0.580.9-0.98-0.94-0.45-0.84-0.460.72-0.34-0.64-0.58-0.96-0.86-0.130.87-0.85-0.14-0.93-0.38-0.1-0.460.180.150.26
0.450.470.320.280.380.40.15-0.40.510.350.010.520.17-0.20.850.90.690.240.44-0.28-0.360.53-0.10.23-0.38-0.240.90.11-0.410.02
-0.080.36-0.11-0.15-0.04-0.140.18-0.08-0.050.22-0.45-0.140.77-0.05-0.16-0.07-0.490.03-0.03-0.5-0.09-0.10.00.12-0.1-0.24-0.25-0.140.440.59
0.50.620.320.40.420.450.17-0.490.60.41-0.080.610.3-0.250.880.910.810.360.58-0.41-0.480.66-0.210.39-0.460.9-0.250.14-0.480.13
-0.18-0.14-0.21-0.04-0.22-0.3-0.170.18-0.14-0.350.11-0.27-0.010.110.150.11-0.07-0.21-0.070.00.17-0.14-0.21-0.120.180.11-0.140.14-0.790.13
-0.19-0.13-0.05-0.34-0.1-0.070.020.15-0.280.05-0.24-0.210.10.1-0.32-0.43-0.5-0.15-0.25-0.060.13-0.260.34-0.190.15-0.410.44-0.48-0.790.08
-0.380.38-0.46-0.46-0.41-0.42-0.090.22-0.28-0.13-0.82-0.20.580.220.080.1-0.16-0.35-0.06-0.90.11-0.09-0.29-0.130.260.020.590.130.130.08
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Biogen Common Stock Shares Outstanding

Common Stock Shares Outstanding

282.98 Million

At present, Biogen's Common Stock Shares Outstanding is projected to decrease significantly based on the last few years of reporting.
Based on the latest financial disclosure, Biogen Inc has 145.36 M of shares currently outstending. This is 19.48% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 74.58% higher than that of the company.

Biogen Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biogen's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biogen could also be used in its relative valuation, which is a method of valuing Biogen by comparing valuation metrics of similar companies.
Biogen is currently under evaluation in shares outstanding category among related companies.

Biogen ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Biogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Biogen's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Biogen Fundamentals

About Biogen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Common Stock Shares Outstanding145.6 M283 M

Pair Trading with Biogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biogen Stock

  0.8MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Biogen Stock

  0.92EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.9DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.81MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.81MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.77TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.55)
Earnings Share
7.96
Revenue Per Share
67.972
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0458
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.